Evaluation of Novartis Access:

An (NCD) medicine access initiative

Boston University is evaluating Novartis Access, a social business program to increase access to medicines for non-communicable diseases (NCDs) through the direct sale of NCD medicines to governments and other public-sector customers in low and lower middle income countries.

Explore the evaluation and related features.

What makes this evaluation unique?

Use of multiple complementary methods such as:

  • Cluster-randomized controlled trial
  • Serial qualitative interviews
  • Telephonic monitoring as an input into the evaluation